Market Closed -
Other stock markets
|
After market 01:50:05 pm | |||
3.184 EUR | -2.03% |
|
3.205 | +0.66% |
02:26pm | Valneva's Chikungunya Vaccine Secures Approval for Use in EU | MT |
Jun. 26 | Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.54% | 484M | |
+38.65% | 39.1B | |
-8.58% | 38.76B | |
+27.52% | 31.24B | |
+12.03% | 25.9B | |
-13.50% | 25.8B | |
+45.22% | 14.06B | |
+36.69% | 13.12B | |
-7.24% | 11.32B | |
-12.52% | 10.68B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva Secures Canadian Approval for Chikungunya Vaccine